Addition of interleukin-6 inhibition with tocilizumab to standard graft-versus-host disease prophylaxis after allogeneic stem-cell transplantation: A phase 1/2 trial
Glen A Kennedy, Antiopi Varelias, Slavica Vuckovic, Laetitia Le Texier, Kate H Gartlan, Ping Zhang, Gethin Thomas, Lisa Anderson, Glen Boyle, Nicole Cloonan, Justin Leach, Elise Sturgeon, Judy Avery, Stuart D Olver, Mary Lor, Ashish K. Misra, Cheryl Hutchins, A James Morton, Simon TS Durrant, Elango SubramoniapillaiJason P Butler, Cameron I Curley, Kelli PA MacDonald, Siok-Keen Tey, Geoffrey R Hill
Dive into the research topics of 'Addition of interleukin-6 inhibition with tocilizumab to standard graft-versus-host disease prophylaxis after allogeneic stem-cell transplantation: A phase 1/2 trial'. Together they form a unique fingerprint.